Summary
A series of leucine dipeptide amides containing at their N-terminal amino group the salicyl-residue [(o)-RO-C6H4-CO-, where R=H or CH3CO] have been synthesized by conventional solution techniques and tested for their inhibitory activity on human platelet aggregationin vitro induced by collagen, ADP or adrenaline. The salicyl-peptide (o)-HO-C6H4-CO-Leu-Asp(OBzl)-NH2 was found to exert strong inhibitory activity on platelet aggregation induced by collagen with an IC50 value 4.5 mM. The corresponding dipetide H2N-Leu-Asp(OVzl)-NH2 was also examined and was found to be less active, indicating that the presence of the lipophilicβ-benzyl ester group in combination with the salicyl group enhance the inhibitory activity. All the other salicyl-peptides examined either didn't show any inhibitory or aggregatory activity or a slight inhibition at the concentration of 9–10 mm.
Similar content being viewed by others
Abbreviations
- ADP:
-
adenosine diphosphate
- Boc:
-
tert-butyloxycarbonyl
- Bzl:
-
benzyl
- DIEA:
-
N,N-diisopropylethylamine
- DMSO:
-
dimethyl sulfoxide
- DMF:
-
N,N-dimethylformamide
- EtOAc:
-
ethyl acetate
- FCC:
-
flash column chromatography
- IC50 :
-
molar concentration of salicyl-peptide for 50% inhibition of platelet aggregation
- iso-BCF:
-
isobutyl chloroformate
- NMM:
-
N-methylmorpholine
- PyBOP:
-
(benzotriazol-1-yloxy) tripyrrolidinophosphonium hexafluorophosphate
- TLC:
-
thin layer chromatography
- TMS:
-
tetramethylsilane
References
Baenziger NL, Dillender MJ, Majerus PW (1977) Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglantin. Bioch Bioph Res Comm 78: 294–301
Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927–929
Callahan JF et al (1992) Design and synthesis of a C7 mimetic for the predictedy-turn conformation found in several constrained RGD antagonists. J Med Chem 35: 3970–3972
Coste J, Le-Nguyen D, Castro B (1990) Oxybenzotriazole free peptide coupling reagents for N-methylated amino acids. Tetrahedron Let 32: 205–208
Das J, Kimball SD (1995) Thrombin active site inhibitors. Bioorg Med Chem 3: 999–1007
Gartner TK, Bennett JS (1985) The tetrapeptide analogue of the cell attachment site of fibronenctin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem 260: 11891–11894
Karagiannis K, Stavropoulos G, Poulos C, Jordan CC, Hagan RM (1993) Synthesis of a potent antagonist of Substance P by replacing the CH2SCH3 and the α-carboxamide groups of the methionine at [Orn6]-SP6–11 by benzyl ester groups. Int J Peptide Protein Res 42: 565–569
Krstenansky JL, Mao SJT (1987) Antithrombin properties of C-terminus of hirudin using synthetic unsulfated Nα-acetyl-hirudin45–65. FEBS Let 211: 10–16
Ku TW et al (1993) Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of highly constrained cyclic RGD peptide. J Am Chem Soc 115: 8861–8862
Liakopoulou-Kyriakides M, Stavropoulos G, Karagiannis C, Calogridis P, Sinakos Z (1990) Effect of Leu-(Asp, Asn, Glu, Gln) dipeptides on platelet aggregationin vitro. Biochem Int 22: 617–625
Liakopoulou-Kyriakides M, Stavropoulos G (1992) Effect of X-Asp (or Asn)-Phe-NH2 (Where X; H, Met) peptides on human platelet aggregationin vitro. Biochem Int 26: 249–256
Muramatsu R, Komatsu Y, Nukui E, Okayama T, Morikawa T, Kobashi K, Hayashi H, (1996) Structure-activity studies on C-terminal hirudin peptides containing sulfated tyrosine residues. Int J Peptide Protein Res 48: 167–173
Nishino N, Hayashida J, Arai T, Mihara H, Ueno Y, Kumagai H (1996) Cyclo(-arginylsarcosyl-aspartyl-phenylglycyl)2. Simple synthesis of an RGD-related peptide with inhibitory activity for platelet aggregation. J Chem Soc Perkin 1: 939–946
Ojima I, Chakravarty S, Dong Q (1995) Antithrombotic agents: from RGD to peptide mimetics. Bioorg Med Chem 3: 337–360
Owen TJ, Krstenansky JL, Yates MT, Mao SJT (1988) N-Terminal requirements of small peptide anticoagulants based on hirudin54–65. J Med Chem 31: 1009–1011
Pierschbacher MD, Ruoslahti E (1984) Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309: 30–33
Ruoslahti E, Pierschbacher MD (1987) New perspectives in cell adhesion: RGD and integrins. Science 238: 491–497
Weiss HJ, Aledort LM (1967) Impaired platelet/connective-tissue reaction in man after aspirin ingestion. Lancet ii: 495–497
Witting JI, Bourdon P, Brezniak DV, Maraganore JM, Fenton JW (1992) Thrombinspecific inhibition by and slow clevage of hirulog-1. Biochem J 283: 737–743
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stavropoulos, G., Magafa, V., Liakopoulou-Kyriakides, M. et al. Synthesis of salicyl-peptides and their effect on human platelet aggregationin vitro . Amino Acids 13, 171–181 (1997). https://doi.org/10.1007/BF01373215
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01373215